Refresh

ALEMBIC PHARMACEUTICALS LTD. - Announcement under Regulation 30 (LODR)-Press Release / Media Release


Download
21 Nov 2022
With reference to the captioned subject, this is to inform the exchange that the Company has received US Food & Drug Administration (USFDA) Final Approval for Nifedipine Extended-Release Tablets USP, 30 mg, 60 mg and 90 mg.

Source: BSE India

View all announcements for ALEMBIC PHARMACEUTICALS LTD.
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com